Phase I Trial of Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
Phase of Trial: Phase I
Latest Information Update: 14 Jun 2018
At a glance
- Drugs Ribociclib (Primary) ; Carboplatin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 07 Jun 2018 Planned number of patients changed from 40 to 42.
- 07 Jun 2018 Planned End Date changed from 1 Feb 2019 to 1 Aug 2021.
- 07 Jun 2018 Planned primary completion date changed from 1 Nov 2018 to 1 Jun 2020.